IP Verse

Teva Pharmaceutical Industries Ltd opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Teva Pharmaceutical Industries Ltd

Patent Number:
EP3263106
Title:
Method For Suppressing Bitterness Of Quinoline Derivative
Applicant:
EISAI R&D MANAGEMENT CO., LTD.
Opposition Date:
Jul 12, 2024
Patent Number:
EP3626270
Title:
New Use
Applicant:
NOVARTIS AG
Opposition Date:
Jul 10, 2024
Patent Number:
EP3634463
Title:
Improved Protocol For Treatment Of Lupus Nephritis
Applicant:
AURINIA PHARMACEUTICALS INC.
Opposition Date:
Jun 26, 2024
Patent Number:
EP3370729
Title:
Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple Myeloma
Applicant:
CELGENE CORPORATION
Opposition Date:
Jun 25, 2024
Patent Number:
EP3639841
Title:
Treating Fibrosis By Inhibiting Tl1A
Applicant:
CEDARS-SINAI MEDICAL CENTER
Opposition Date:
Jun 4, 2024
Patent Number:
EP3110449
Title:
Medical Use Of A Dpp-4 Inhibitor
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Mar 21, 2024
Patent Number:
EP3858405
Title:
Syringe
Applicant:
NOVARTIS AG
Opposition Date:
Jan 5, 2024
Patent Number:
EP3294283
Title:
Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure
Applicant:
NOVARTIS AG
Opposition Date:
Dec 7, 2023
Patent Number:
EP2981272
Title:
Microporous Zirconium Silicate And Diuretics For The Reduction Of Potassium And Treatment Of Chronic Kidney And/Or Chronic Heart Disease
Applicant:
ZS PHARMA, INC
Opposition Date:
Nov 22, 2023
Patent Number:
EP3880197
Title:
Methods Of Treatment For Cystic Fibrosis
Applicant:
VERTEX PHARMACEUTICALS INCORPORATED
Opposition Date:
Nov 22, 2023

Competitors of Teva Pharmaceutical Industries Ltd

NOVARTIS AG

NOVO NORDISK A/S

PFIZER INC.

Want to track Teva Pharmaceutical Industries Ltd?

Feel free to send us a message here and we will get back to you